Skip to main content

Table 1 Patient/sample characteristics with known ARID1A mutation status according to histotype

From: A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation

 

Clear cell

Endometrioid

Serous

Characteristic

No. (%)

No. (%)

No. (%)

  Stage

   

  1/2

19 (61)

21 (88)

6 (17)

  3/4

11 (35)

2 (8)

29 (83)

  Missing

1 (3)

1 (3)

 

ARID1A mutation

   

  No

14 (45)

19 (79)

35 (100)

  Yes

17 (55)

5 (21)

0 (0)

PIK3CA mutation

   

  None

17 (55)

13 (54)

NT

  Helical

7 (23)

4 (17)

NT

  Kinase

4 (13)

4 (17)

NT

  Other

3 (9)

3 (12)

NT

  1. NT = not tested.